Topco Scientific Co.,Ltd. (TPE:5434)
283.00
+1.00 (0.35%)
Mar 14, 2025, 1:35 PM CST
Topco Scientific Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Operating Revenue | 54,768 | 46,944 | 50,555 | 41,098 | 35,233 | Upgrade
|
Other Revenue | 2,229 | 2,329 | 2,423 | 1,571 | 934.93 | Upgrade
|
Revenue | 56,997 | 49,273 | 52,978 | 42,669 | 36,168 | Upgrade
|
Revenue Growth (YoY) | 15.68% | -6.99% | 24.16% | 17.97% | 14.09% | Upgrade
|
Cost of Revenue | 49,279 | 42,855 | 46,453 | 37,457 | 31,863 | Upgrade
|
Gross Profit | 7,718 | 6,419 | 6,525 | 5,212 | 4,305 | Upgrade
|
Selling, General & Admin | 3,712 | 3,091 | 3,139 | 2,559 | 2,143 | Upgrade
|
Research & Development | 66.64 | 117.48 | 156.41 | 101.17 | 100.23 | Upgrade
|
Other Operating Expenses | -4.26 | 12.02 | -0.29 | -0.29 | -0.29 | Upgrade
|
Operating Expenses | 3,775 | 3,221 | 3,296 | 2,660 | 2,243 | Upgrade
|
Operating Income | 3,943 | 3,198 | 3,230 | 2,552 | 2,062 | Upgrade
|
Interest Expense | -113.68 | -99.57 | -53.11 | -34.23 | -27.17 | Upgrade
|
Interest & Investment Income | 79.64 | 190.85 | 122.91 | 60.98 | 59.38 | Upgrade
|
Earnings From Equity Investments | 609.81 | 471.82 | 541.72 | 422.68 | 373.35 | Upgrade
|
Currency Exchange Gain (Loss) | - | -13.74 | 123.55 | -38.39 | -44.91 | Upgrade
|
Other Non Operating Income (Expenses) | 210.29 | 78.86 | 54.96 | 50.18 | 34.93 | Upgrade
|
EBT Excluding Unusual Items | 4,729 | 3,826 | 4,020 | 3,013 | 2,457 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -0.12 | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | 80.15 | 248.5 | 45.27 | 7.6 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -26.11 | -26.65 | -8.53 | 94.55 | Upgrade
|
Asset Writedown | - | - | - | -10.03 | - | Upgrade
|
Pretax Income | 4,729 | 3,880 | 4,242 | 3,040 | 2,559 | Upgrade
|
Income Tax Expense | 1,064 | 1,028 | 1,167 | 738.89 | 494.1 | Upgrade
|
Earnings From Continuing Operations | 3,665 | 2,853 | 3,075 | 2,301 | 2,065 | Upgrade
|
Minority Interest in Earnings | -9.16 | -17.89 | -56.7 | -6.5 | 3.03 | Upgrade
|
Net Income | 3,656 | 2,835 | 3,018 | 2,294 | 2,068 | Upgrade
|
Net Income to Common | 3,656 | 2,835 | 3,018 | 2,294 | 2,068 | Upgrade
|
Net Income Growth | 28.96% | -6.08% | 31.56% | 10.93% | 20.09% | Upgrade
|
Shares Outstanding (Basic) | 190 | 185 | 182 | 182 | 182 | Upgrade
|
Shares Outstanding (Diluted) | 195 | 189 | 184 | 183 | 183 | Upgrade
|
Shares Change (YoY) | 2.91% | 2.84% | 0.48% | -0.09% | 0.23% | Upgrade
|
EPS (Basic) | 19.29 | 15.36 | 16.61 | 12.63 | 11.38 | Upgrade
|
EPS (Diluted) | 18.78 | 15.03 | 16.41 | 12.53 | 11.29 | Upgrade
|
EPS Growth | 24.92% | -8.39% | 30.97% | 10.98% | 19.85% | Upgrade
|
Free Cash Flow | 866.68 | -152.61 | 2,815 | 2,191 | 1,734 | Upgrade
|
Free Cash Flow Per Share | 4.45 | -0.81 | 15.30 | 11.97 | 9.46 | Upgrade
|
Dividend Per Share | - | 9.000 | 6.000 | 8.800 | 8.000 | Upgrade
|
Dividend Growth | - | 50.00% | -31.82% | 10.00% | 23.08% | Upgrade
|
Gross Margin | 13.54% | 13.03% | 12.32% | 12.22% | 11.90% | Upgrade
|
Operating Margin | 6.92% | 6.49% | 6.10% | 5.98% | 5.70% | Upgrade
|
Profit Margin | 6.41% | 5.75% | 5.70% | 5.38% | 5.72% | Upgrade
|
Free Cash Flow Margin | 1.52% | -0.31% | 5.31% | 5.14% | 4.79% | Upgrade
|
EBITDA | 4,424 | 3,526 | 3,547 | 2,816 | 2,269 | Upgrade
|
EBITDA Margin | 7.76% | 7.16% | 6.69% | 6.60% | 6.27% | Upgrade
|
D&A For EBITDA | 480.95 | 327.86 | 316.89 | 263.9 | 207.72 | Upgrade
|
EBIT | 3,943 | 3,198 | 3,230 | 2,552 | 2,062 | Upgrade
|
EBIT Margin | 6.92% | 6.49% | 6.10% | 5.98% | 5.70% | Upgrade
|
Effective Tax Rate | 22.50% | 26.48% | 27.50% | 24.31% | 19.31% | Upgrade
|
Revenue as Reported | 56,997 | 49,273 | 52,978 | 42,669 | 36,168 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.